# Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

> **NCT04144192** · PHASE1 · COMPLETED · sponsor: **Scilex Pharmaceuticals, Inc.** · enrollment: 58 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lidocaine patch 1.8%
- **DRUG:** Lidocaine 5% patch
- **DRUG:** Lidocaine 2% Injectable Solution

## Key facts

- **NCT ID:** NCT04144192
- **Lead sponsor:** Scilex Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-28
- **Primary completion:** 2014-07-24
- **Final completion:** 2014-07-24
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04144192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04144192, "Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04144192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*